Evidence map›Paper›PMID 28842629›Full record

ArticleScientific reports2017

Bone marrow-derived cells and their conditioned medium induce microvascular repair in uremic rats by stimulation of endogenous repair mechanisms.

Lina Golle, Hans U Gerth, Katrin Beul, Barbara Heitplatz, Peter Barth, Manfred Fobker, Hermann Pavenstädt, Giovana S Di Marco, Marcus Brand

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 31 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Small vessel disease: Connections between the kidney and the heart.American heart journal plus : cardiology research and practice · 2023
    Article
  5. Review
  6. Clinical Proteomics of Biofluids in Haematological Malignancies.International journal of molecular sciences · 2021
    Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Stem Cell Therapies in Kidney Diseases: Progress and Challenges.International journal of molecular sciences · 2019
    Review
  14. Article
  15. Bone marrow-derived mesenchymal stromal cell: what next?Stem cells and cloning : advances and applications · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Lina GolleDepartment of Internal Medicine D, University Hospital Muenster, Muenster, Germany.
Hans U GerthDepartment of Internal Medicine D, University Hospital Muenster, Muenster, Germany.
Katrin BeulDepartment of Internal Medicine D, University Hospital Muenster, Muenster, Germany.
Barbara HeitplatzDepartment of Pathology, University Hospital Muenster, Muenster, Germany.
Peter BarthDepartment of Pathology, University Hospital Muenster, Muenster, Germany.
Manfred FobkerCentre for Laboratory Medicine, University of Münster, Münster, Germany.
Hermann PavenstädtDepartment of Internal Medicine D, University Hospital Muenster, Muenster, Germany.
Giovana S Di MarcoDepartment of Internal Medicine D, University Hospital Muenster, Muenster, Germany. giodimarco@gmail.com.
Marcus BrandDepartment of Internal Medicine D, University Hospital Muenster, Muenster, Germany.
University Hospital Münster · DEUniversity of Münster · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The reduced number of circulating stem/progenitor cells that is found in chronic kidney disease (CKD) patients may contribute to impaired angiogenic repair and decreased capillary density in the heart. Cell therapy with bone marrow-derived cells (BMDCs) has been shown to induce positive effects on the microvasculature and cardiac function, most likely due to secretion of growth factors and cytokines, all of which are present in the conditioned medium (CM); however, this is controversial. Here we showed that treatment with BMDC or CM restored vascular density and decreased the extent of fibrosis in a rat model of CKD, the 5/6 nephrectomy. Engraftment and differentiation of exogenous BMDCs could not be detected. Yet CM led to the mobilization and infiltration of endogenous circulating cells into the heart. Cell recruitment was facilitated by the local expression of pro-inflammatory factors such as the macrophage chemoattractant protein-1, interleukin-6, and endothelial adhesion molecules. Consistently, in vitro assays showed that CM increased endothelial adhesiveness to circulating cells by upregulating the expression of adhesion molecules, and stimulated angiogenesis/endothelial tube formation. Overall, our results suggest that both treatments exert vasculoprotective effects on the heart of uremic rats by stimulating endogenous repair mechanisms.

Indexed as

Bone Marrow TransplantationAnimalsBone Marrow CellsChemokine CCL2Coronary VesselsCulture Media, ConditionedDisease Models, AnimalHumansInterleukin-6KidneyMaleNeovascularization, PhysiologicRatsRats, Sprague-DawleyRenal Insufficiency, ChronicUremiaCcl2 protein, ratChemokine CCL2Culture Media, ConditionedInterleukin-6

Identifiers

PMID28842629
PMCPMC5572734
OpenAlexW2746278718

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.